PlainRecalls
FDA Devices Moderate Class II Terminated

ST-AIA PACK C-Peptide; Part Number: 025284 Assay, Diabetes

Reported: June 13, 2018 Initiated: March 5, 2018 #Z-2074-2018

Product Description

ST-AIA PACK C-Peptide; Part Number: 025284 Assay, Diabetes

Reason for Recall

Asfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.

Details

Recalling Firm
Tosoh Bioscience Inc
Units Affected
1358
Distribution
Worldwide Distribution: US (Nationwide) and countries of; Canada, Mexico, Columbia, Chile, Uruguay, Nicaragua, Argentina, Peru, Chile, Honduras. Equador, Caymen Islands, Panama, and Costa Rica.
Location
Grove City, OH

Frequently Asked Questions

What product was recalled?
ST-AIA PACK C-Peptide; Part Number: 025284 Assay, Diabetes. Recalled by Tosoh Bioscience Inc. Units affected: 1358.
Why was this product recalled?
Asfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 13, 2018. Severity: Moderate. Recall number: Z-2074-2018.